Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
Base Salary, Level B $122,830 - $145,858 p.a. (pro-rata) + 17% superannuation About the opportunity Applications are invited for the appointment of a Postdoctoral Researcher in Quantum Information Theory
-
fixed term position, Level A, Base Salary $105,314 - $112,690 + 17% superannuation About the opportunity We are seeking an ambitious and talented Postdoctoral Research Associate to undertake fundamental
-
Full time research position, initial two-year fixed term with possibility of extension Opportunity to lead a research program in peptide drug discovery Located at the Chemistry Building (F11
-
and evolution of fault and fracture systems to crustal-to-lithospheric scale deformation responsible for the formation of sedimentary basins and mountain belts. This 3-year, full-time postdoctoral
-
motivated and skilled Postdoctoral Researcher (Atomic, Molecular, and Optical Physics & Photonic Integrated Circuits). Working in the Precision Measurement Group, you will work with a team towards using
-
sedimentologic and structural, on the subsurface flow and interactions of hydrogen upon injection and subsequent recovery. This postdoctoral research associate will work in collaboration with colleagues
-
contribution of 17% superannuation applies. Fixed term, full-time position for 3 years. This postdoctoral role will investigate the impact H2 –Cushion-gas–Brine–Rock interactions on static and dynamic properties
-
applications for our Postdoctoral Fellowship positions across a wide range of diverse and cutting-edge fields. Opportunities exist within our well-funded research areas such as AI, Intelligent Secure Systems
-
the SAiGENCI Cancer Epigenetics program and ACE strive to unravel the epigenetic mechanisms contributing to cell fate, development and cancer, with the aim of developing effective therapeutics. The postdoctoral
-
Doctoral Scientist position. This position will report to Professor Jose Polo, Lead of the Cancer Epigenetics Program at the South Australian Immunogenomics Cancer Institute (SAiGENCI) and the Inaugural